hypog01:unicancer phase 3 trial of locoregional hypo vs normo fractionated rt in early breast cancer
Published 1 year ago • 94 plays • Length 2:11Download video MP4
Download video MP3
Similar videos
-
1:10
skagen & hypog-01 trials: hypofractionated rt in early breast cancer reduces arm lymphedema risk
-
2:08
evolution of fractionation regimens in breast cancer radiotherapy: skagen trial 1 and hypog-01 trial
-
1:24
the potential of moderately hypofractionated radiotherapy: analysis & future directions
-
1:42
fast forward phase iii: hypofractionated whole breast irradiation
-
0:50
dr. jagsi discusses the benefits of hypofractionated radiotherapy for breast cancer
-
2:45
paloma-3: phase 3 trial of fulvestrant with palbociclib for metastatic breast cancer
-
1:12
monarche: adjuvant abemaciclib in hr breast cancer
-
5:06
safety outcomes in the phase iii monarche trial of abemaciclib et in hr , her2- breast cancer
-
0:53
final results of the phase 3 data trial assessing aromatase inhibition in hr breast cancer
-
0:15
3 year cancer survivor - stage 4 breast cancer at 22 #shorts
-
4:37
predict underestimates survival of patients with her2 early breast cancer
-
0:48
evaluating the safety of t-dxd with radiotherapy in her2 metastatic breast cancer
-
0:22
detect lung cancer early
-
1:09
areas of unmet need regarding oncoplastic breast conservation
-
0:19
what is stage 4 breast cancer? #breastcancer
-
1:49
phase ib data capitello-292: capivasertib palbociclib fulvestrant in hr /her2- breast cancer
-
1:24
oligometastatic diseases (omd) in breast cancer
-
1:36
phase 3 trial investigates t-dm1 and pertuzumab in her2 breast cancer